ON-DEMAND WEBINARS

Drug developers, researchers, patients, and regulators are recognizing the benefits of sensor-based digital health technologies for clinical research.

Beyond enabling data collection outside the clinic, new models are enhancing stakeholders' abilities to access more sensitive, frequent, and objective measures of Parkinson’s progression. 

A candid look at balancing resource constraints with rigorous clinical strategy to earn trust, reimbursement, and real growth.

Chief Scientific Officer Christine Guo, Ph.D., provides key insights into DHTs aimed at empowering study teams to strategically integrate these technologies into their clinical development initiatives.

ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS

John Oncea Editor